Latest total revenue for HEXO: $120M, below the Healthcare sector average of $110B.
Get informed when a big investor buys or sells
+ FollowAs of Apr 2023
Trailing 12 months ending Apr 2023
HEXO posts a total revenue of $120M as of April 2023. That compares with $190M in the prior-year period — down 33.7% year over year. That is below the Healthcare sector average of $110B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, HEXO's total revenue was $190M. The latest reading is $120M — a 33.7% year-over-year decrease (period ending April 2023). Use the history and growth charts on this page for a longer lookback.
For Healthcare stocks, a total revenue near $110B is typical. HEXO's $120M is lower that level. That is roughly 99.9% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Total Revenue is one piece of HEXO's financial statement story. At $120M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for HEXO's total revenue usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $110B), and (3) consistency with growth and profitability. This page covers the first two; HEXO's other metric pages and overview cover the third.